04:33 PM EDT, 10/10/2024 (MT Newswires) -- Richard E Lowenthal, 10% Owner, Director, President and CEO, on October 08, 2024, sold 100,000 shares in Ars Pharmaceuticals ( SPRY ) for $1,382,775. Following the Form 4 filing with the SEC, Lowenthal has control over a total of 10,519,106 shares of the company, with 4,315,313 shares held directly and 6,203,793 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1671858/000141588924024980/xslF345X05/form4-10102024_081026.xml